MDS Congress 2025 Session Evaluation

MDS Congress 2025 Session 1103 Evaluation Form
Therapeutic Plenary Session 1103

Device-Aided and Surgical Therapies for Parkinson’s Disease

October 5, 2025

13:30 - 15:00
Learning Objectives:

1. Analyze efficacy, tolerability, and safety of apomorphine therapies and levodopa infusions in Parkinson’s disease
2. Analyze efficacy, tolerability, and safety of DBS and MR-guided focused ultrasound in Parkinson’s disease
3. Assess the criteria for patient selection for each of these methods
Session Evaluation
The session met its learning objectives

Strongly agreeAgreeDisagreeStrongly disagree
The content is relevant to my professional and / or scientific interests.

Strongly agreeAgreeDisagreeStrongly disagree
The quality of the education process (method of presentation and information provided) was satisfactory and appropriate.

Strongly agreeAgreeDisagreeStrongly disagree
The information provided will enhance my care of patients with Movement Disorders and / or advance my scientific understanding of Movement Disorders.

Strongly agreeAgreeDisagreeStrongly disagree
The overall session organization was satisfactory and appropriate.

Strongly agreeAgreeDisagreeStrongly disagree
I would recommend this session to a colleague.

Strongly agreeAgreeDisagreeStrongly disagree
Faculty Assessment
K. Ray Chaudhuri, United Kingdom
This speaker was able to effectively communicate the content of their presentation

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
Elena Moro, France
This speaker was able to effectively communicate the content of their presentation

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
Thomas Kimber, Australia
This speaker was able to effectively communicate the content of their presentation

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
How would you improve this activity?
Please provide any additional comments
The following category best describes your current major professional activity (choose one):

Patient managementBasic Science researchClinical ResearchTeachingResident/PhD StudentUndergraduate StudentOther
My country:
Should be Empty:

MDS Congress 2025 Session 1103 Evaluation Form

Therapeutic Plenary Session 1103

Device-Aided and Surgical Therapies for Parkinson’s Disease